IMUX
Immunic Inc
9.30$
+0.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | -32.4% | +13.0% | +19.2% | +35.5% | -16.7% | +22.9% | +0.0% | – | – | -21.4% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -2.6% | -2.8% | -2.2% | +16.6% | +1.2% | -0.4% | -0.8% | -6.4% | -4.7% | +34.4% | +1.2% | – | |
| – | +8.6% | +25.6% | -12.7% | -3.0% | -7.9% | +31.8% | +8.0% | +4.7% | -28.8% | +77.9% | +24.0% | – | |
| – | -0.9% | +2.1% | -4.5% | +12.9% | -0.5% | +4.8% | +1.0% | -4.0% | -10.3% | +42.3% | +6.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -100.5% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.